Vergoeding 2020-2024 voor ATC-subgroep L04AX : Overige immunosuppressiva
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| L04AX01 Azathioprine (Imuran ®) | 1.901.900 | 1.713.800 | 1.637.600 | 1.670.700 | 1.551.800 |
| L04AX03 Methotrexaat (Injexate ®) | 21.861.800 | 20.240.900 | 19.127.400 | 18.442.900 | 18.551.600 |
| L04AX05 Pirfenidon (Esbriet ®) | 10.670.100 | 10.045.200 | 11.031.700 | 10.048.500 | 8.188.700 |
| L04AX07 Dimethylfumaraat (Skilarence ®) | 51.348.100 | 51.535.400 | 52.725.500 | 51.481.500 | 48.703.000 |
| L04AX09 Diroximelfumaraat (Vumerity ®) | . | . | 2.095.200 | 5.570.100 | 6.709.600 |
| Totaal | 85.781.900 | 83.535.300 | 86.617.400 | 87.213.700 | 83.704.700 |